📰 Iris Pharma News
Page 2 - Iris Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iris Pharma. Real-time updates on events, politics, business and more.
December 6, 2021
IRIS Pharma becomes a subsidiary of ABIONYX Pharma and remains independent in its service activities for major pharmaceutical and biotech companies in the ophthalmology sector A potential
December 6, 2021
IRIS Pharma becomes a subsidiary of ABIONYX Pharma and remains independent in its service activities for major pharmaceutical and biotech companies in
December 2, 2021
Regulatory News: ABIONYX Pharma (Paris:ABNX) (FR0012616852 ABNX PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients
December 2, 2021
Regulatory News: ABIONYX Pharma (PARIS:ABNX) (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and
December 2, 2021
TOULOUSE, France--(BUSINESS WIRE)--Regulatory News:ABIONYX Pharma (Paris:ABNX) (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces the success of its capital increase in cash by a private placement...
December 17, 2020
Press release content from Wired Release. The AP news staff was not involved in its creation. Juvenile Macular Degeneration Treatment Market 2021 – Global Research, Recent Trends and Growth Forecast To 2026 December 17, 2020 GMT Pune, Maharashtra, India, December 17 2020 (Wiredrelease) MarketDesk :The research report Global Juvenile Macular Degeneration Treatment Market Industry Analysis 2021-2026 covers all the major trends and drivers playing a key part in the development of the Life Scienc...